Search
Filter Results
Displaying 31–40 of 573 for “clinical trials wet amd”
-
Apr 30, 2024
Age-Related Macular Degeneration Research Advances
Recent developments in research on age-related macular degeneration.
-
Nov 18, 2022
Foundation Insights Forum – November 10, 2022
The Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the inherited retinal disease community. The call took place on November 10, 2022.
-
Aug 18, 2021
Foundation Insights Forum – August 12, 2021
The Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the inherited retinal disease community. The call took place on August 12, 2021.
-
May 23, 2023
Summary of the Eighth Annual Retinal Cell & Gene Therapy Innovation Summit 2023
The Retinal Cell and Gene Therapy Innovation Summit has emerged as one of the most essential events for researchers and companies developing treatments and cures for retinal degenerative diseases. In its eighth year, the Innovation Summit featured 30 presentations from retina experts from around the world with more than 300 people in attendance.
-
Feb 9, 2012
The Foundation's 5 Most Asked Questions About Clinical Trials
What you need to know (and what to expect) about clinical trials.
-
Mar 8, 2022
Trial recruitment is enabled by the Foundation Fighting Blindness’ patient registry, My Retina Tracker® Registry, which includes genetic and vision information for more than 20,000 people with inherited retinal diseases.
-
Jul 31, 2018
Forty High-Impact Retinal-Research Efforts Highlighted at FFB-Casey Innovation Summit
In its fifth year, the Innovation Summit featured 40 presentations from industry experts from around the world.
-
Apr 14, 2015
Need-to-Know Information about Clinical Trials
A primer on what you can expect from clinical trials.
-
Dec 21, 2018
Applied Genetic Technologies Corporation (AGTC), a leading developer of gene therapies, has reported the six-month follow-up data in all patients treated with its gene therapy for X-linked retinoschisis (XLRS) in its Phase I/II clinical trial.
-
Jun 1, 2017
Valproic Acid's Effect Too Small in One-Year Clinical Trial
While a therapy for adRP will not emerge from the clinical trial, study investigators advanced development of a new outcome measure known as EZ Area to quickly and accurately evaluate potential therapies for RP in human studies.